Nontuberculous mycobacteria in respiratory infections: Advances in diagnosis and identification

Clinics in Laboratory Medicine

Volumn 34, Issue 2, 2014, Pages 271-295

  Somoskovi, Akos ^a   Salfinger, Max ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Antimicrobial susceptibility testing; Identification; Mycobacterium; Nontuberculous mycobacteria; NTM

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; LINEZOLID; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; SULFONAMIDE;

ACID FAST MICROSCOPY; AGE DISTRIBUTION; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIUM DETECTION; CULTURE MEDIUM; CULTURE SYSTEM; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DNA SEQUENCE; GENOMICS; HUMAN; LABORATORY DIAGNOSIS; LINE PROBE ASSAY BASED TEST; LIQUID CULTURE; MICROSCOPY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEX DIFFERENCE; SOLID CULTURE; AGED; CLASSIFICATION; DRUG EFFECTS; FEMALE; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PROCEDURES; RESPIRATORY TRACT INFECTIONS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; RESPIRATORY TRACT INFECTIONS;

EID: 84901192317     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2014.03.001     Document Type: Review

References (104)

1. Griffith D.E., Aksamit T., Brown-Elliott B.A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175(4):367-416.
2. Somoskovi A., Mester J., Hale Y.M., et al. Laboratory diagnosis of nontuberculous mycobacteria. Clin Chest Med 2002, 23(3):585-597.
3. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003, 16(2):319-354.
4. Tortoli E. The new mycobacteria: an update. FEMS Immunol Med Microbiol 2006, 48(2):159-178.
5. Tortoli E. Phylogeny of the genus Mycobacterium: many doubts, few certainties. Infect Genet Evol 2012, 12(4):827-831.
6. Aitken M.L., Limaye A., Pottinger P., et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 2012, 185(2):231-232.
7. Bryant J.M., Grogono D.M., Greaves D., et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013, 381(9877):1551-1560.
8. Brown-Elliott B.A., Nash K.A., Wallace R.J. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012, 25(3):545-582.
9. Prevots D.R., Shaw P.A., Strickland D., et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010, 182(7):970-976.
10. Marras T.K., Chedore P., Ying A.M., et al. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007, 62(8):661-666.
11. Marras T.K., Mendelson D., Marchand-Austin A., et al. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis 2013, 19(11):1889-1891.
12. Billinger M.E., Olivier K.N., Viboud C., et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009, 15(10):1562-1569.
13. Adjemian J., Olivier K.N., Seitz A.E., et al. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012, 185(8):881-886.
14. Gubler J.G., Salfinger M., von Graevenitz A. Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest 1992, 101(5):1245-1249.
15. Honeybourne D., Neumann C.S. An audit of bronchoscopy practice in the United Kingdom: a survey of adherence to national guidelines. Thorax 1997, 52(8):709-713.
16. Kaul K., Luke S., McGurn C., et al. Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR results. JClin Microbiol 1996, 34(8):1949-1951.
17. Mehta A.C., Prakash U.B., Garland R., et al. American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. Chest 2005, 128(3):1742-1755.
18. Kent P.T., Kubica G.P. Public health mycobacteriology. A guide for a level III laboratory 1985, Center for Disease Control and Prevention, Atlanta (GA).
19. Tang Y.W., Procop G.W., Zheng X., et al. Histologic parameters predictive of mycobacterial infection. Am J Clin Pathol 1998, 109(3):331-334.
20. Pfyffer G.E., Palicova F. Mycobacterium: general characteristics, laboratory detection, and staining procedures. Manual of clinical microbiology 2011, 472-502. American Society for Microbiology, Washington, DC. 10th edition. J. Versalovic, K.C. Carroll, J.H. Jorgensen (Eds.).
21. Whittier S., Olivier K., Gilligan P., et al. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. JClin Microbiol 1997, 35(10):2706-2708.
22. De Bel A., De Geyter D., De Schutter I., et al. Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients. JClin Microbiol 2013, 51(12):4204-4206.
23. Somoskovi A., Hotaling J.E., Fitzgerald M., et al. Lessons from a proficiency testing event for acid-fast microscopy. Chest 2001, 120(1):250-257.
24. Ebersole L.L. Acid-fast staining procedures. Clinical microbiology procedures handbook 1992, vol. 1. American Society for Microbiology, Washington, DC, p. 3.5.1-3.5.11.
25. Salfinger M., Pfyffer G.E. The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis 1994, 13(11):961-979.
26. Gruft H. Evaluation of mycobacteriology laboratories: the acid-fast smear. Health Lab Sci 1978, 15(4):215-220.
27. Lipsky B.A., Gates J., Tenover F.C., et al. Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis 1984, 6(2):214-222.
28. Van Deun A., Maug A.K., Hossain A., et al. Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis. Int J Tuberc Lung Dis 2012, 16(9):1174-1179.
29. Fennelly K.P., Morais C.G., Hadad D.J., et al. The small membrane filter method of microscopy to diagnose pulmonary tuberculosis. JClin Microbiol 2012, 50(6):2096-2099.
30. Quinco P., Buhrer-Sekula S., Brandao W., et al. Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy. JClin Microbiol 2013, 51(9):2921-2925.
31. Bernard C., Wichlacz C., Rigoreau M., et al. Evaluation of the Fluo-RAL module for detection of tuberculous and nontuberculous acid-fast bacilli by fluorescence microscopy. JClin Microbiol 2013, 51(10):3469-3470.
32. Minion J., Pai M., Ramsay A., et al. Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting. PLoS One 2011, 6(7):e22495.
33. CLSI Laboratory detection and identification of Mycobacteria. CLSI document M48-A 2008, Approved Guideline, Clinical and Laboratory Standards Institute, Wayne (PA).
34. Centers for Disease Control and Prevention (CDC) Update: nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000, 49(26):593-594.
35. Omar S.V., Roth A., Ismail N.A., et al. Analytical performance of the Roche LightCycler(R) Mycobacterium Detection Kit for the diagnosis of clinically important mycobacterial species. PLoS One 2011, 6(9):e24789.
36. Franco-Alvarez de Luna F., Ruiz P., Gutierrez J., et al. Evaluation of the GenoType Mycobacteria Direct assay for detection of Mycobacterium tuberculosis complex and four atypical mycobacterial species in clinical samples. JClin Microbiol 2006, 44(8):3025-3027.
37. Syre H., Myneedu V.P., Arora V.K., et al. Direct detection of mycobacterial species in pulmonary specimens by two rapid amplification tests, the gen-probe amplified mycobacterium tuberculosis direct test and the genotype mycobacteria direct test. JClin Microbiol 2009, 47(11):3635-3639.
38. Mitarai S., Kato S., Ogata H., et al. Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2012, 50(3):884-890.
39. Styrt B.A., Shinnick T.M., Ridderhof J.C., et al. Turnaround times for mycobacterial cultures. JClin Microbiol 1997, 35(4):1041-1042.
40. Benjamin W.H., Waites K.B., Beverly A., et al. Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens. JClin Microbiol 1998, 36(11):3234-3238.
41. Hanna B.A., Ebrahimzadeh A., Elliott L.B., et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. JClin Microbiol 1999, 37(3):748-752.
42. Pfyffer G.E., Cieslak C., Welscher H.M., et al. Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solid-culture systems. JClin Microbiol 1997, 35(9):2229-2234.
43. Somoskovi A., Magyar P. Comparison of the mycobacteria growth indicator tube with MB Redox, Lowenstein-Jensen, and Middlebrook 7H11 media for recovery of mycobacteria in clinical specimens. JClin Microbiol 1999, 37(5):1366-1369.
44. Tortoli E., Cichero P., Chirillo M.G., et al. Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. JClin Microbiol 1998, 36(5):1378-1381.
45. Stockman L. Blood culture for mycobacteria: isolator method. Clinical microbiology procedures handbook 1992, American Society for Microbiology, Washington, DC, p. 3.9.1-3.9.5. H.D. Isenberg (Ed.).
46. Brittle W., Marais B.J., Hesseling A.C., et al. Improvement in mycobacterial yield and reduced time to detection in pediatric samples by use of a nutrient broth growth supplement. JClin Microbiol 2009, 47(5):1287-1289.
47. White D.A., Kiehn T.E., Bondoc A.Y., et al. Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med 1999, 160(4):1366-1368.
48. Whittington R.J., Whittington A.M., Waldron A., et al. Development and validation of a liquid medium (M7H9C) for routine culture of Mycobacterium avium subsp. paratuberculosis to replace modified Bactec 12B medium. JClin Microbiol 2013, 51(12):3993-4000.
49. Thomsen V.O., Dragsted U.B., Bauer J., et al. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. JClin Microbiol 1999, 37(12):3901-3905.
50. Portaels F., Pattyn S.R. Growth of mycobacteria in relation to the pH of the medium. Ann Microbiol (Paris) 1982, 133(2):213-221.
51. Somoskovi A., Hotaling J.E., Fitzgerald M., et al. False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay. JClin Microbiol 2000, 38(7):2743-2745.
52. Cloud J.L., Neal H., Rosenberry R., et al. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. JClin Microbiol 2002, 40(2):400-406.
53. Richter E., Niemann S., Rusch-Gerdes S., et al. Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques. JClin Microbiol 1999, 37(4):964-970.
54. Zheng X., Pang M., Engler H.D., et al. Rapid detection of Mycobacterium tuberculosis in contaminated BACTEC 12B broth cultures by testing with Amplified Mycobacterium Tuberculosis Direct Test. JClin Microbiol 2001, 39(10):3718-3720.
55. Wallace R.J., Iakhiaeva E., Williams M.D., et al. Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. JClin Microbiol 2013, 51(6):1747-1752.
56. Ichimura S., Nagano M., Ito N., et al. Evaluation of the invader assay with the BACTEC MGIT 960 system for prompt isolation and identification of mycobacterial species from clinical specimens. JClin Microbiol 2007, 45(10):3316-3322.
57. Taylor T.B., Patterson C., Hale Y., et al. Routine use of PCR-restriction fragment length polymorphism analysis for identification of mycobacteria growing in liquid media. JClin Microbiol 1997, 35(1):79-85.
58. Telenti A., Marchesi F., Balz M., et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. JClin Microbiol 1993, 31(2):175-178.
59. Brunello F., Ligozzi M., Cristelli E., et al. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. JClin Microbiol 2001, 39(8):2799-2806.
60. Sajduda A., Martin A., Portaels F., et al. hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae-Mycobacterium abscessus group. Int J Infect Dis 2012, 16(3):e193-e197.
61. Kim B.J., Lee K.H., Park B.N., et al. Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB). JClin Microbiol 2001, 39(6):2102-2109.
62. Roth A., Reischl U., Streubel A., et al. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. JClin Microbiol 2000, 38(3):1094-1104.
63. Takewaki S., Okuzumi K., Manabe I., et al. Nucleotide sequence comparison of the mycobacterial dnaJ gene and PCR-restriction fragment length polymorphism analysis for identification of mycobacterial species. Int J Syst Bacteriol 1994, 44(1):159-166.
64. Makinen J., Marjamaki M., Marttila H., et al. Evaluation of a novel strip test, GenoType Mycobacterium CM/AS, for species identification of mycobacterial cultures. Clin Microbiol Infect 2006, 12(5):481-483.
65. Makinen J., Sarkola A., Marjamaki M., et al. Evaluation of genotype and LiPA MYCOBACTERIA assays for identification of Finnish mycobacterial isolates. JClin Microbiol 2002, 40(9):3478-3481.
66. Russo C., Tortoli E., Menichella D. Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. JClin Microbiol 2006, 44(2):334-339.
67. Tortoli E. Identification of mycobacteria by using INNO LiPA. JClin Microbiol 2002, 40(8):3111.
68. Tortoli E., Mariottini A., Mazzarelli G. Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. JClin Microbiol 2003, 41(9):4418-4420.
69. Perandin F., Pinsi G., Signorini C., et al. Evaluation of INNO-LiPA assay for direct detection of mycobacteria in pulmonary and extrapulmonary specimens. New Microbiol 2006, 29(2):133-138.
70. Quezel-Guerraz N.M., Arriaza M.M., Avila J.A., et al. Evaluation of the Speed-oligo(R) Mycobacteria assay for identification of Mycobacterium spp. from fresh liquid and solid cultures of human clinical samples. Diagn Microbiol Infect Dis 2010, 68(2):123-131.
71. Kirschner P., Bottger E.C. Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol 1998, 101:349-361.
72. Kirschner P., Rosenau J., Springer B., et al. Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. JClin Microbiol 1996, 34(2):304-312.
73. Kirschner P., Springer B., Vogel U., et al. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. JClin Microbiol 1993, 31(11):2882-2889.
74. Kasai H., Ezaki T., Harayama S. Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences. JClin Microbiol 2000, 38(1):301-308.
75. Kim B.J., Lee S.H., Lyu M.A., et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). JClin Microbiol 1999, 37(6):1714-1720.
76. Macheras E., Roux A.L., Ripoll F., et al. Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. JClin Microbiol 2009, 47(8):2596-2600.
77. Olsen R.J., Cernoch P.A., Austin C.M., et al. Validation of the MycoAlign system forMycobacterium spp. identification. Diagn Microbiol Infect Dis 2007, 59(1):105-108.
78. Ringuet H., Akoua-Koffi C., Honore S., et al. hsp65 sequencing for identification of rapidly growing mycobacteria. JClin Microbiol 1999, 37(3):852-857.
79. Roth A., Fischer M., Hamid M.E., et al. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. JClin Microbiol 1998, 36(1):139-147.
80. Sassi M., Ben Kahla I., Drancourt M. Mycobacterium abscessus multispacer sequence typing. BMC Microbiol 2013, 13:3.
81. Soini H., Bottger E.C., Viljanen M.K. Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. JClin Microbiol 1994, 32(12):2944-2947.
82. Yamada-Noda M., Ohkusu K., Hata H., et al. Mycobacterium species identification-a new approach via dnaJ gene sequencing. Syst Appl Microbiol 2007, 30(6):453-462.
83. Turenne C.Y., Tschetter L., Wolfe J., et al. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. JClin Microbiol 2001, 39(10):3637-3648.
84. Koh W.J., Jeon K., Lee N.Y., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011, 183(3):405-410.
85. Koh W.J., Jeong B.H., Jeon K., et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease. Chest 2012, 142(6):1482-1488.
86. Leao S.C., Tortoli E., Euzeby J.P., et al. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol 2011, 61(Pt 9):2311-2313.
87. Macheras E., Konjek J., Roux A.L., et al. Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Res Microbiol 2014, 165(2):82-90. 10.1016/j.resmic.2013.12.003.
88. Shallom S.J., Gardina P.J., Myers T.G., et al. New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. JClin Microbiol 2013, 51(9):2943-2949.
89. Simmon K.E., Kommedal O., Saebo O., et al. Simultaneous sequence analysis of the 16S rRNA and rpoB genes by use of RipSeq software to identify Mycobacterium species. JClin Microbiol 2010, 48(9):3231-3235.
90. Mather C.A., Rivera S.F., Butler-Wu S.M. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. JClin Microbiol 2014, 52(1):130-138.
91. Jagielski T., Van Ingen J., Rastogi N., et al. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. BioMed Res Int 2014, 2014:645802.
92. Kikuchi T., Watanabe A., Gomi K., et al. Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection. Thorax 2009, 64(10):901-907.
93. Kim S.Y., Lee S.T., Jeong B.H., et al. Clinical significance of mycobacterial genotyping in Mycobacterium avium lung disease in Korea. Int J Tuberc Lung Dis 2012, 16(10):1393-1399.
94. Shin S.J., Choi G.E., Cho S.N., et al. Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis 2013, 57(1):32-39.
95. Tatano Y., Sano C., Yasumoto K., et al. Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates. Eur J Clin Microbiol Infect Dis 2012, 31(4):445-454.
96. CLSI Susceptibility testing of mycobacteria, norcardiae and other aerobic actinomycetes 2011, CLSI Document M24-A2, Clinical and Laboratory Standards Institute, Wayne (PA). Approved Standard-Second edition.
97. Hombach M., Somoskovi A., Homke R., et al. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST. Int J Med Microbiol 2013, 303(5):270-276.
98. Turnidge J., Paterson D.L. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 2007, 20(3):391-408. [table of contents].
99. Choi G.E., Shin S.J., Won C.J., et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med 2012, 186(9):917-925.
100. Maurer F.P., Castelberg C., Quiblier C., et al. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. JAntimicrob Chemother 2014, [Epub ahead of print].
101. Christianson S., Grierson W., Wolfe J., et al. Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet?. JClin Microbiol 2013, 51(7):2425-2426.
102. Meier A., Kirschner P., Springer B., et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrobial Agents Chemother 1994, 38(2):381-384.
103. Maurer F.P., Ruegger V., Ritter C., et al. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). JAntimicrob Chemother 2012, 67(11):2606-2611.
104. Daley C.L., Glassroth J. Treatment of pulmonary nontuberculous mycobacterial infections: many questions remain. Ann Am Thorac Soc 2014, 11(1):96-97.